This chapter examines the complex processes underlying biotech commercialization from the perspective of the firm and industry. More specifically, it considers how biotech industries have been organized in Korea, Taiwan, and Singapore. It identifies the core actors in the biotech innovation system, the range of relevant supporting actors, and the strategic interactions between biotech firms, labs, and the state. It also explores how decision makers in three countries strategically rationalize the ways in which the bio-industry is organized. While they face similar challenges in betting against biotech's myriad sources of uncertainty, the chapter shows that decision makers in Korea, Taiwan, and Singapore have organized the bio-industry using quite different strategic rationales.
Cornell Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.
If you think you should have access to this title, please contact your librarian.
To troubleshoot, please check our FAQs, and if you can't find the answer there, please contact us.